Chemed
About: Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Employees: 15,695
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
150% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 5 (+3) [Q1 2025]
59% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 54
57% more call options, than puts
Call options by funds: $8.12M | Put options by funds: $5.16M
13% more capital invested
Capital invested by funds: $7.35B [Q4 2024] → $8.34B (+$988M) [Q1 2025]
4% more funds holding
Funds holding: 527 [Q4 2024] → 547 (+20) [Q1 2025]
0.03% less ownership
Funds ownership: 92.67% [Q4 2024] → 92.64% (-0.03%) [Q1 2025]
8% less repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 196
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$640
39%
upside
Avg. target
$645
40%
upside
High target
$650
41%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
RBC Capital Ben Hendrix | 39%upside $640 | Outperform Maintained | 30 Jun 2025 |
B of A Securities Joanna Gajuk | 41%upside $650 | Buy Maintained | 30 Jun 2025 |
Financial journalist opinion
Neutral
Zacks Investment Research
1 day ago
ASTH or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Business Wire
2 weeks ago
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Med.
Neutral
Zacks Investment Research
1 month ago
AMED or CHE: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
1 month ago
Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Neutral
Business Wire
1 month ago
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cas.
Neutral
Business Wire
1 month ago
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. L.
Neutral
Seeking Alpha
1 month ago
Chemtrade Logistics Income Fund (CGIFF) Q1 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Rohit Bhardwaj – Chief Financial Officer Scott Rook – President and Chief Executive Officer Conference Call Participants Joel Jackson – BMO Capital Markets Gary Ho – Desjardins Capital Markets Nelson Ng – RBC Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund First Quarter 2025 Conference Call. I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.
Neutral
Business Wire
2 months ago
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and.
Positive
Zacks Investment Research
2 months ago
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
2 months ago
CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
Charts implemented using Lightweight Charts™